These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2223152)
1. Inhibitory effect of bestatin on the growth of human leukemic cells. Sakurada K; Imamura M; Kobayashi M; Tachibana N; Abe K; Tanaka M; Okabe M; Morioka M; Kasai M; Sugiura T Acta Oncol; 1990; 29(6):799-802. PubMed ID: 2223152 [TBL] [Abstract][Full Text] [Related]
2. Enhancing effect of ubenimex (bestatin) on proliferation and differentiation of hematopoietic progenitor cells, and the suppressive effect on proliferation of leukemic cell lines via peptidase regulation. Shibuya K; Chiba S; Hino M; Kitamura T; Miyagawa K; Takaku F; Miyazano K Biomed Pharmacother; 1991; 45(2-3):71-80. PubMed ID: 1912372 [TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines. Sekine K; Fujii H; Abe F Leukemia; 1999 May; 13(5):729-34. PubMed ID: 10374877 [TBL] [Abstract][Full Text] [Related]
4. [Growth inhibitory effects of ubenimex on leukemic cell lines resistant to chemotherapeutic agents]. Fujii H; Yosizawa K; Maruyama S; Abe F Jpn J Antibiot; 1996 Dec; 49(12):1109-15. PubMed ID: 9032597 [TBL] [Abstract][Full Text] [Related]
5. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells. Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of bestatin on the growth of human lymphocytes. Ino K; Isobe K; Goto S; Nakashima I; Tomoda Y Immunopharmacology; 1992; 23(3):163-71. PubMed ID: 1500283 [TBL] [Abstract][Full Text] [Related]
7. Effects of bestatin (Ubenimex) on human T-cell colony formation. Wakabayashi Y; Hashimoto M; Saitoh K; Osawa H; Koike M; Hirose S Anticancer Drugs; 1991 Feb; 2(1):39-43. PubMed ID: 1835660 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Saiki I; Murata J; Watanabe K; Fujii H; Abe F; Azuma I Jpn J Cancer Res; 1989 Sep; 80(9):873-8. PubMed ID: 2513304 [TBL] [Abstract][Full Text] [Related]
9. Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines. Sekine K; Fujii H; Abe F; Nishikawa K Int J Cancer; 2001 Nov; 94(4):485-91. PubMed ID: 11745433 [TBL] [Abstract][Full Text] [Related]
10. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N. Imamura N; Kimura A Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A. Ueda M; Ueki M; Fujii H; Yoshizawa K; Nakajima M J Med; 1997; 28(3-4):175-90. PubMed ID: 9355022 [TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines. Ezawa K; Minato K; Dobashi K Biomed Pharmacother; 1996; 50(6-7):283-9. PubMed ID: 8952869 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin). Yoneda J; Saiki I; Fujii H; Abe F; Kojima Y; Azuma I Clin Exp Metastasis; 1992 Jan; 10(1):49-59. PubMed ID: 1733647 [TBL] [Abstract][Full Text] [Related]
14. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity. Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606 [TBL] [Abstract][Full Text] [Related]
15. Bestatin, an inhibitor of aminopeptidase B, suppresses the proliferation and differentiation of human B-cells in vitro. Morikawa K; Morikawa S; Nakano A; Oseko F Int J Immunopharmacol; 1989; 11(8):905-13. PubMed ID: 2613395 [TBL] [Abstract][Full Text] [Related]
16. Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S. Fujioka S; Kohno N; Hiwada K Jpn J Cancer Res; 1995 Apr; 86(4):368-73. PubMed ID: 7775259 [TBL] [Abstract][Full Text] [Related]
17. Ubenimex treatment enhances the susceptibility of gastric cancer cell lines to lymphokine-activated killer cells. Iwahashi M; Tanimura H; Yamaue H; Tani M; Noguchi K; Mizobata S; Tsunoda T; Tamai M; Hotta T; Arii K Anticancer Res; 1994; 14(4A):1563-8. PubMed ID: 7979186 [TBL] [Abstract][Full Text] [Related]
18. Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells. Murata M; Kubota Y; Tanaka T; Iida-Tanaka K; Takahara J; Irino S Leukemia; 1994 Dec; 8(12):2188-93. PubMed ID: 7528860 [TBL] [Abstract][Full Text] [Related]
19. Induction of DNA polymerase alpha and terminal deoxynucleotidyl transferase in the human lymphoblastoid cell line Molt-4 by the immunomodulator bestatin. Leyhausen G; Dippold W; Zahn RK; Meyer zum Büschenfelde KH; Umezawa H; Müller WE Immunopharmacology; 1984 Jun; 7(3-4):151-7. PubMed ID: 6590537 [TBL] [Abstract][Full Text] [Related]
20. [Effect of APN/CD13 on bestatin enhancing all-trans-retinoic acid-inducing differentiation in NB4 cells]. Qian XJ; Lin MF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1125-8. PubMed ID: 22040956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]